GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orchid Ventures Inc (XCNQ:ORCD) » Definitions » EPS (Diluted)

Orchid Ventures (XCNQ:ORCD) EPS (Diluted) : C$-0.08 (TTM As of Mar. 2022)


View and export this data going back to 2011. Start your Free Trial

What is Orchid Ventures EPS (Diluted)?

Orchid Ventures's Earnings per Share (Diluted) for the three months ended in Mar. 2022 was C$-0.01. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2022 was C$-0.08.

Orchid Ventures's EPS (Basic) for the three months ended in Mar. 2022 was C$-0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2022 was C$-0.08.

Orchid Ventures's EPS without NRI for the three months ended in Mar. 2022 was C$-0.01. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2022 was C$-0.08.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Orchid Ventures EPS (Diluted) Historical Data

The historical data trend for Orchid Ventures's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orchid Ventures EPS (Diluted) Chart

Orchid Ventures Annual Data
Trend Apr11 Apr12 Apr13 Apr14 Apr15 Apr16 Apr17 Apr18 May19 Jun21
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.16 -0.51 -0.16 -4.58 -0.13

Orchid Ventures Quarterly Data
Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 May19 Aug19 Nov19 Feb20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.05 -0.05 -0.01 -0.01 -0.01

Competitive Comparison of Orchid Ventures's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Orchid Ventures's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orchid Ventures's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orchid Ventures's PE Ratio distribution charts can be found below:

* The bar in red indicates where Orchid Ventures's PE Ratio falls into.



Orchid Ventures EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Orchid Ventures's Diluted EPS for the fiscal year that ended in Jun. 2021 is calculated as

Diluted EPS (A: Jun. 2021 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-3.851-0)/29.602
=-0.13

Orchid Ventures's Diluted EPS for the quarter that ended in Mar. 2022 is calculated as

Diluted EPS (Q: Mar. 2022 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.484-0)/50.471
=-0.01

EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Orchid Ventures  (XCNQ:ORCD) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Orchid Ventures EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Orchid Ventures's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Orchid Ventures (XCNQ:ORCD) Business Description

Traded in Other Exchanges
N/A
Address
27762 Antonio Parkway Ste L-1-631, Ladera Ranch, CA, USA, 92694
Orchid Ventures Inc is engaged in product development, branding, manufacturing, and distribution of vape products containing cannabis. It is a cannabis brand with THC and CBD product lines. Some of its vape products include Orchid Gold, Orchid Classics, Orchid Vibes, Orchid Roots and The Beast Orchid's Battery. It operates in a single geographical segment, which is North America.

Orchid Ventures (XCNQ:ORCD) Headlines

No Headlines